Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)

Determining the Risk of Fetal Loss in Women With Unprovoked Venous Thromboembolism (VTE) Who Do NOT Have Identifiable Inherited Thrombophilia Compared With Women Who Have the Diagnosis of VTE Excluded

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00149357

Enrollment

239

Registered

2005-09-08

Start date

2005-07-31

Completion date

2008-12-31

Last updated

2017-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Death, Venous Thromboembolism

Keywords

venous thromboembolism, VTE, thrombophilia, fetal loss

Brief summary

The purpose of this study is to determine the risk of fetal loss in women with unprovoked venous thromboembolism (VTE) who do not have identifiable inherited thrombophilia compared with women who have the diagnosis of venous thromboembolism (VTE) excluded.

Interventions

OTHERThrombophilia Testing

TP testing in Group 1 and 3 only

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Female * At least 18 years of age * Symptomatic for unprovoked venous thromboembolism (deep vein thrombosis \[DVT\] or pulmonary embolism \[PE\]) * At least one pregnancy not terminated intentionally

Exclusion criteria

* Previous VTE in patients with current VTE excluded

Countries

Australia, Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026